Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:33377624

Overexpression of chemokine receptor lymphotactin receptor 1 has prognostic value in clear cell renal cell carcinoma.

Xian Chang · Ya Cao · Wan-Lei Fu · Xue-Feng Tang · Ya-Li Wang · Yang-Fan Lv · Qiao-Nan Guo

Molecular genetics & genomic medicine · 2021 doi:10.1002/mgg3.1551

Paper

complete

Experiment

partial

Data

partial

Analysis

partial

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:33377624
kind
science-record
content_hash
sha256:ff17cc4d988bce875c41909cc5f7c5d11166f50c698e491c344cd326e2102186
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T15:41:20Z
updated_at
2026-11-01T21:24:24Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
Overexpression of chemokine receptor lymphotactin receptor 1 has prognostic value in clear cell renal cell carcinoma.
doi
10.1002/mgg3.1551
pmid
33377624
authors array · 7 items
[0]
Xian Chang
[1]
Ya Cao
[2]
Wan-Lei Fu
[3]
Xue-Feng Tang
[4]
Ya-Li Wang
[5]
Yang-Fan Lv
[6]
Qiao-Nan Guo
journal
Molecular genetics & genomic medicine
year
2021
abstract
BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is an aggressive subtype of renal cell carcinoma. X-C motif chemokine receptor 1 (XCR1) exerts important roles in tumor progression; however, its role in ccRCC is unclear. METHODS: We utilized publicly available data from The Cancer Genome Atlas (TCGA) to assess the role of XCR1 in ccRCC and validated the results in 36 samples from patients with ccRCC who underwent curative resection in Xinqiao Hospital Chongqing. XCR1 overexpression was identified in ccRCC, which was confirmed by qRT-PCR assay and immunohistochemical staining of ccRCC samples. RESULTS: For the TCGA and clinical data, Kaplan-Meier survival analysis revealed that higher XCR1 expression in ccRCC was related to longer overall survival. Cox regression analysis suggested that XCR1 is an independent risk factor for ccRCC. GSEA analysis suggested that XCR1 is associated with the JAK/STAT signaling pathway. XCR1 knockdown by small interfering RNA (siRNA) significantly increased ccRCC cell proliferation and migration, and decreased cell apoptosis. CONCLUSION: We found higher XCR1 expression in ccRCC compared with that in normal tissues is related to longer overall survival in patients with ccRCC. XCR1 knockdown significantly increased RCC cells proliferation and migration, and decreased apoptosis. XCR1 might be used as a prognostic biomarker in ccRCC in the future.
claims array · 2 items
[0] object · 6 fields
id
claim-method
statement
For association analysis between IHC samples and clinical‐pathological parameters analysis, the Pearson χ2 test was used.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:33377624
locator
sections[12] "Statistical analysis" paragraph 2
quote
For association analysis between IHC samples and clinical‐pathological parameters analysis, the Pearson χ2 test was used.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
The data of this study are available from the corresponding author upon reasonable request.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:33377624
locator
sections[24] "DATA AVAILABILITY STATEMENT" paragraph 2
quote
The data of this study are available from the corresponding author upon reasonable request.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
partial
objective
null
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:33377624
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
blocked
blocked_on
data:accession_absent
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 1 item
[0]
step:obtain_source_data blocked on data:accession_absent
data object · 3 fields
state
partial
assets array · 7 items
[0] object · 15 fields
id
source:pmid:33377624
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.1002/mgg3.1551
sha256
sha256:83314057bc52dff9b921e4474f1f1a12a70f87bcfce09158716a3995230b4369
bytes
27594
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.1002/mgg3.1551
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC7963425
source
europe_pmc_fulltext
coverage
whole_body_without_references
text_hash_scope
rendered_section_body
[1] object · 16 fields
id
asset:table:pmid:33377624:1
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:ee82daf49171e43162a2ffb549ed06807aa557a9194c79b674f472b5fba1d5be
bytes
406
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[7]/table-wrap[1]#mgg31551-tbl-0001
version
null
note
Primer pairs used for real‐time PCR.
structure object · 5 fields
pmcid
PMC7963425
section_index
7
section_title
RNA extraction, reverse transcription, and quantitative real‐time PCR
row_count
3
column_count
3
table object · 8 fields
label
Table 1
caption
Primer pairs used for real‐time PCR.
rows array · 3 items
[0] array · 3 items
[0]
Gene
[1]
Forward primer sequence (5′ to 3′)
[2]
Reverse primer sequence (5′ to 3′)
[1] array · 3 items
[0]
GAPDH
[1]
CGCTGAGTACGTCGTGGAGTC
[2]
GCTGATGATCTTGAGGCTGTTGTC
[2] array · 3 items
[0]
XCR1
[1]
TACCTCACCTCCGTCTACCA
[2]
GATGAGCAGGGCGTATTCTA
locator
section[7]/table-wrap[1]#mgg31551-tbl-0001
[2] object · 16 fields
id
asset:table:pmid:33377624:2
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:0f75e6632bfc58dc5d8b633589bf3e44d4abfc376896e129522df3993fe64080
bytes
684
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[14]/table-wrap[1]#mgg31551-tbl-0002
version
null
note
Clinicopathological features of patients included in this study.
structure object · 5 fields
pmcid
PMC7963425
section_index
14
section_title
Patient characteristics
row_count
22
column_count
3
table object · 8 fields
label
Table 2
caption
Clinicopathological features of patients included in this study.
rows array · 22 items
[0] array · 3 items
[0]
[1]
TCGA database
[2]
Clinical Samples
[1] array · 3 items
[0]
Total
[1]
539
[2]
36
[2] array · 3 items
[0]
Age
[1]
26–90 (61)
[2]
24–78 (56)
[3] array · 1 item
[0]
Gender
[4] array · 3 items
[0]
Male
[1]
348
[2]
23
[5] array · 3 items
[0]
Female
[1]
191
[2]
13
[6] array · 1 item
[0]
Grade
[7] array · 3 items
[0]
G1
[1]
14
[2]
3
[8] array · 3 items
[0]
G2
[1]
230
[2]
13
[9] array · 3 items
[0]
G3
[1]
207
[2]
15
[10] array · 3 items
[0]
G4
[1]
78
[2]
5
[11] array · 3 items
[0]
NA
[1]
10
[2]
0
[12] array · 1 item
[0]
TNM staging
[13] array · 3 items
[0]
Ⅰ
[1]
269
[2]
11
[14] array · 3 items
[0]
Ⅱ
[1]
57
[2]
15
[15] array · 3 items
[0]
Ⅲ
[1]
125
[2]
8
[16] array · 3 items
[0]
Ⅳ
[1]
83
[2]
2
[17] array · 3 items
[0]
NA
[1]
5
[2]
0
[18] array · 3 items
[0]
Follow‐up, months
[1]
0–121
[2]
20–83
[19] array · 1 item
[0]
Survival condition
[20] array · 3 items
[0]
Dead
[1]
172
[2]
8
[21] array · 3 items
[0]
Alive
[1]
367
[2]
28
locator
section[14]/table-wrap[1]#mgg31551-tbl-0002
[3] object · 16 fields
id
asset:table:pmid:33377624:3
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:56dca27834fc6e06d8a86501ce576dae25a22aaa79b849ef7d1b22d994d20394
bytes
690
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[16]/table-wrap[1]#mgg31551-tbl-0003
version
null
note
Association between XCR1 expression and the clinic‐pathological characteristics of clinical samples from ccRCC patients.
structure object · 5 fields
pmcid
PMC7963425
section_index
16
section_title
Correlation between XCR1 expression and ccRCC malignancy
row_count
18
column_count
4
table object · 8 fields
label
Table 3
caption
Association between XCR1 expression and the clinic‐pathological characteristics of clinical samples from ccRCC patients.
rows array · 18 items
[0] array · 4 items
[0]
Characteristics
[1]
Positive
[2]
Negative
[3]
P‐value
[1] array · 4 items
[0]
Age
[1]
[2]
[3]
[2] array · 4 items
[0]
<45
[1]
7
[2]
4
[3]
0.984
[3] array · 4 items
[0]
≥45
[1]
16
[2]
9
[3]
[4] array · 4 items
[0]
[1]
[2]
[3]
[5] array · 4 items
[0]
Gender
[1]
14
[2]
9
[3]
[6] array · 4 items
[0]
Male
[1]
9
[2]
4
[3]
0.621
[7] array · 3 items
[0]
female
[1]
[2]
[8] array · 4 items
[0]
Grade
[1]
2
[2]
1
[3]
[9] array · 4 items
[0]
Ⅰ
[1]
5
[2]
8
[3]
0.125
[10] array · 4 items
[0]
Ⅱ
[1]
12
[2]
3
[3]
[11] array · 4 items
[0]
Ⅲ
[1]
4
[2]
1
[3]
[12] array · 4 items
[0]
Ⅳ
[1]
[2]
[3]
[13] array · 4 items
[0]
TNM staging
[1]
8
[2]
3
[3]
[14] array · 4 items
[0]
Ⅰ
[1]
3
[2]
12
[3]
0.019
[15] array · 4 items
[0]
Ⅱ
[1]
1
[2]
7
[3]
[16] array · 4 items
[0]
Ⅲ
[1]
1
[2]
1
[3]
[17] array · 4 items
[0]
Ⅳ
[1]
[2]
[3]
locator
section[16]/table-wrap[1]#mgg31551-tbl-0003
[4] object · 16 fields
id
asset:table:pmid:33377624:4
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:a69b139059ae2ea2876df46d01d56c219858b7b11576cdc4cde3a017edc05ec9
bytes
1055
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[16]/table-wrap[2]#mgg31551-tbl-0004
version
null
note
Cox regression analysis of XCR1 mRNA levels and patient overall survival with ccRCC.
structure object · 5 fields
pmcid
PMC7963425
section_index
16
section_title
Correlation between XCR1 expression and ccRCC malignancy
row_count
9
column_count
9
table object · 8 fields
label
Table 4
caption
Cox regression analysis of XCR1 mRNA levels and patient overall survival with ccRCC.
rows array · 9 items
[0] array · 3 items
[0]
Variable
[1]
Univariate analysis
[2]
Multivariate analysis
[1] array · 8 items
[0]
HR
[1]
HR.95L
[2]
HR.95H
[3]
P value
[4]
HR
[5]
HR.95L
[6]
HR.95H
[7]
P value
[2] array · 9 items
[0]
age
[1]
1.032826
[2]
1.019083
[3]
1.046754
[4]
2.29E−06
[5]
1.034216
[6]
1.018615
[7]
1.050057
[8]
1.44E−05
[3] array · 9 items
[0]
Sex
[1]
0.931081
[2]
0.675354
[3]
1.283641
[4]
0.662937
[5]
0.962538
[6]
0.692753
[7]
1.337389
[8]
0.820013
[4] array · 9 items
[0]
Grade
[1]
2.293061
[2]
1.854092
[3]
2.835959
[4]
1.94E−14
[5]
1.652044
[6]
1.294088
[7]
2.109014
[8]
5.60E−05
[5] array · 9 items
[0]
Stage
[1]
1.888786
[2]
1.648774
[3]
2.163737
[4]
4.67E−20
[5]
1.707664
[6]
1.076801
[7]
2.708128
[8]
0.022938
[6] array · 9 items
[0]
T
[1]
1.94139
[2]
1.639292
[3]
2.29916
[4]
1.50E−14
[5]
0.86604
[6]
0.566668
[7]
1.32357
[8]
0.506312
[7] array · 9 items
[0]
M
[1]
4.283544
[2]
3.105734
[3]
5.908024
[4]
7.45E−19
[5]
1.242764
[6]
0.625942
[7]
2.467424
[8]
0.534532
[8] array · 9 items
[0]
XCR1
[1]
0.815312
[2]
0.638049
[3]
1.041823
[4]
0.102594
[5]
0.720596
[6]
0.56334
[7]
0.921749
[8]
0.00909
locator
section[16]/table-wrap[2]#mgg31551-tbl-0004
[5] object · 16 fields
id
asset:table:pmid:33377624:5
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:8e55112a74393e925d0e2de7dbf6e495835853d3f8e3f7f446cff14800131f43
bytes
648
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[17]/table-wrap[1]#mgg31551-tbl-0005
version
null
note
Top five signaling pathways enriched in the XCR1 upregulation group.
structure object · 5 fields
pmcid
PMC7963425
section_index
17
section_title
GSEA identified XCR1‐related signaling pathways
row_count
6
column_count
6
table object · 8 fields
label
Table 5
caption
Top five signaling pathways enriched in the XCR1 upregulation group.
rows array · 6 items
[0] array · 6 items
[0]
Rank
[1]
Name of pathway
[2]
ES
[3]
NES
[4]
NOM p‐val
[5]
FDR q‐val
[1] array · 6 items
[0]
1
[1]
HUNTINGTONS_DISEASE
[2]
0.616067
[3]
2.251294
[4]
0
[5]
0.01076
[2] array · 6 items
[0]
2
[1]
CARDIAC_MUSCLE_CONTRACTION
[2]
0.614087
[3]
2.145381
[4]
0
[5]
0.022747
[3] array · 6 items
[0]
3
[1]
OXIDATIVE_PHOSPHORYLATION
[2]
0.806736
[3]
2.122762
[4]
0
[5]
0.020029
[4] array · 6 items
[0]
4
[1]
BUTANOATE_METABOLISM
[2]
0.714311
[3]
2.092098
[4]
0.004141
[5]
0.019135
[5] array · 6 items
[0]
5
[1]
PARKINSONS_DISEASE
[2]
0.716557
[3]
2.081168
[4]
0.001957
[5]
0.017659
locator
section[17]/table-wrap[1]#mgg31551-tbl-0005
[6] object · 16 fields
id
asset:table:pmid:33377624:6
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:23f65f535d45b04dd223a4a3005e3de7c0bfd1cf4a5cd453684203cca532eacf
bytes
1083
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[17]/table-wrap[2]#mgg31551-tbl-0006
version
null
note
Top 10 signaling pathways enriched in the XCR1 downregulation group.
structure object · 5 fields
pmcid
PMC7963425
section_index
17
section_title
GSEA identified XCR1‐related signaling pathways
row_count
11
column_count
6
table object · 8 fields
label
Table 6
caption
Top 10 signaling pathways enriched in the XCR1 downregulation group.
rows array · 11 items
[0] array · 6 items
[0]
Rank
[1]
Name of pathway
[2]
Es
[3]
NES
[4]
NOM p‐val
[5]
FDR q‐val
[1] array · 6 items
[0]
1
[1]
JAK STAT SIGNALING PATHWAY
[2]
−0.6941993
[3]
−2.92982
[4]
0
[5]
0
[2] array · 6 items
[0]
2
[1]
NON SMALL CELL LUNG CANCER
[2]
−0.55117565
[3]
−1.92028
[4]
0.010204
[5]
0.022405
[3] array · 6 items
[0]
3
[1]
ACUTE MYELOID LEUKEMIA
[2]
−0.5652863
[3]
−1.91111
[4]
0.013834
[5]
0.023524
[4] array · 6 items
[0]
4
[1]
VEGF SIGNALING PATHWAY
[2]
−0.45163378
[3]
−1.90325
[4]
0
[5]
0.02442
[5] array · 6 items
[0]
5
[1]
CHRONIC MYELOID LEUKEMIA
[2]
−0.5741395
[3]
−1.9007
[4]
0.014553
[5]
0.024273
[6] array · 6 items
[0]
6
[1]
PANCREATIC CANCER
[2]
−0.56183416
[3]
−1.88966
[4]
0.02439
[5]
0.025081
[7] array · 6 items
[0]
7
[1]
PATHWAYS IN CANCER
[2]
−0.4609015
[3]
−1.88757
[4]
0.014315
[5]
0.024817
[8] array · 6 items
[0]
8
[1]
SMALL CELL LUNG CANCER
[2]
−0.5270194
[3]
−1.83966
[4]
0.022222
[5]
0.030835
[9] array · 6 items
[0]
9
[1]
COLORECTAL CANCER
[2]
−0.5336979
[3]
−1.78094
[4]
0.027083
[5]
0.043837
[10] array · 6 items
[0]
10
[1]
RENAL CELL CARCINOMA
[2]
−0.53083134
[3]
−1.76747
[4]
0.034836
[5]
0.045633
locator
section[17]/table-wrap[2]#mgg31551-tbl-0006
gaps array · 0 items
analysis object · 4 fields
state
partial
methods array · 4 items
[0] object · 10 fields
id
method-1
family
survival_analysis
specific
kaplan_meier
label
Survival analysis
dsl_operations array · 1 item
[0]
survival_km
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.7
band
medium
quote
Kaplan-Meier
[1] object · 10 fields
id
method-2
family
survival_analysis
specific
cox_proportional_hazards
label
Survival analysis
dsl_operations array · 1 item
[0]
cox_ph
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.7
band
medium
quote
Cox regression
[2] object · 10 fields
id
method-3
family
contingency_analysis
specific
chi_square
label
Categorical (contingency table) analysis
dsl_operations array · 1 item
[0]
chi_square_test
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
categorical_cross_tabulation
evidence object · 3 fields
score
0.8
band
high
quote
χ2
[3] object · 10 fields
id
method-4
family
null
specific
null
label
Pearson χ² test
dsl_operations array · 0 items
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 0 items
evidence object · 3 fields
score
1
band
verbatim
quote
For association analysis between IHC samples and clinical‐pathological parameters analysis, the Pearson χ2 test was used.
targets array · 0 items
gaps array · 1 item
[0]
method.reader_named_unmapped
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
blocked
tier
R4
blocked_on
data:accession_absent
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
true
required_operations array · 1 item
[0]
survival_km
missing_operations array · 0 items
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: kaplan_meier.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R4
reachable
false
accessions array · 0 items
resolved_accessions array · 0 items
statements array · 1 item
[0]
The data of this study are available from the corresponding author upon reasonable request.
basis
The paper names no accession to its source data, so the data has to come from the authors.
can_run object · 3 fields
dsl_operations array · 1 item
[0]
survival_km
assets array · 7 items
[0]
source:pmid:33377624
[1]
asset:table:pmid:33377624:1
[2]
asset:table:pmid:33377624:2
[3]
asset:table:pmid:33377624:3
[4]
asset:table:pmid:33377624:4
[5]
asset:table:pmid:33377624:5
[6]
asset:table:pmid:33377624:6
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:None
gaps array · 1 item
[0]
data:accession_absent
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-10-31T18:25:34Z
independence
single_reader
evidence_check object · 2 fields
method
verbatim
availability
verbatim
calls
3
usage object · 3 fields
prompt_tokens
22004
completion_tokens
1258
cached_tokens
7432
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:33377624
type
paper
label
pmid:33377624
[1] object · 3 fields
id
source:pmid:33377624
type
manuscript
label
PMID 33377624 full text
[2] object · 3 fields
id
data:geo:None
type
dataset
label
GEO None
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:33377624
type
paper
label
pmid:33377624
[1] object · 3 fields
id
source:pmid:33377624
type
manuscript
label
PMID 33377624 full text
[2] object · 3 fields
id
data:geo:None
type
dataset
label
GEO None
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-33377624
type
extraction
used array · 1 item
[0]
source:pmid:33377624
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-None
type
accession_resolution
used array · 1 item
[0]
data:geo:None
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:33377624
parent_hash
sha256:018573f89779b532508840d668c4713df5bb02d7abc42f2d92574dbb942f9c87
fork_of
null
gaps array · 6 items
[0]
execution.not_run
[1]
method.reader_named_unmapped
[2]
review.human_critique
[3]
review.independent_reader
[4]
review.machine_critique
[5]
step:obtain_source_data blocked on data:accession_absent
assays array · 6 items
[0] object · 11 fields
role
data_generation
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 2 items
[0]
CC, which was confirmed by qRT-PCR assay and immunohistochemical staining of ccRCC samples. RESULTS: For the
[1]
ignificant. For association analysis between IHC samples and clinical‐pathological parameters
order_basis
paper_text_order:629
id
assay:1
[1] object · 11 fields
role
data_generation
definition_id
transfection
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 3 items
[0]
ed with the JAK/STAT signaling pathway. XCR1 knockdown by small interfering RNA (siRNA) significant
[1]
verall survival in patients with ccRCC. XCR1 knockdown significantly increased RCC cells proliferat
[2]
ay. XCR1 knockdown by small interfering RNA (siRNA) significantly increased ccRCC cell prolifer
order_basis
paper_text_order:1009
id
assay:2
[2] object · 11 fields
role
data_generation
definition_id
apoptosis_assay
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.93
evidence array · 2 items
[0]
liferation and migration, and decreased cell apoptosis. CONCLUSION: We found higher XCR1 expression
[1]
s proliferation and migration, and decreased apoptosis. XCR1 might be used as a prognostic biomarke
order_basis
paper_text_order:1135
id
assay:3
[3] object · 11 fields
role
data_generation
definition_id
rna_seq
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.93
evidence array · 1 item
[0]
ferential mRNA expression. Subsequently, the RNA sequencing (RNA‐Seq) gene expression level 3 HTSeq‐Coun
order_basis
paper_text_order:1966
id
assay:4
[4] object · 11 fields
role
data_generation
definition_id
cell_culture
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.77
evidence array · 1 item
[0]
ed from the ATCC (Manassas, VA, USA) and was cultured in Roswell Park Memorial Institute (RPMI)‐1640
order_basis
paper_text_order:2524
id
assay:5
[5] object · 11 fields
role
analysis
definition_id
survival_analysis
definition_version
f2132e96ae6c7a4e
required_operations array · 1 item
[0]
survival_km
support_state
supported
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
Kaplan-Meier
order_basis
consumes_earlier_output
id
assay:6
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:33377624", "kind": "science-record", "revision": 6, "content_hash": "sha256:ff17cc4d988bce875c41909cc5f7c5d11166f50c698e491c344cd326e2102186", "created_at": "2026-11-01T15:41:20Z", "updated_at": "2026-11-01T21:24:24Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Overexpression of chemokine receptor lymphotactin receptor 1 has prognostic value in clear cell renal cell carcinoma.", "doi": "10.1002/mgg3.1551", "pmid": "33377624", "authors": ["Xian Chang", "Ya Cao", "Wan-Lei Fu", "Xue-Feng Tang", "Ya-Li Wang", "Yang-Fan Lv", "Qiao-Nan Guo"], "journal": "Molecular genetics & genomic medicine", "year": 2021, "abstract": "BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is an aggressive subtype of renal cell carcinoma. X-C motif chemokine receptor 1 (XCR1) exerts important roles in tumor progression; however, its role in ccRCC is unclear.\nMETHODS: We utilized publicly available data from The Cancer Genome Atlas (TCGA) to assess the role of XCR1 in ccRCC and validated the results in 36 samples from patients with ccRCC who underwent curative resection in Xinqiao Hospital Chongqing. XCR1 overexpression was identified in ccRCC, which was confirmed by qRT-PCR assay and immunohistochemical staining of ccRCC samples.\nRESULTS: For the TCGA and clinical data, Kaplan-Meier survival analysis revealed that higher XCR1 expression in ccRCC was related to longer overall survival. Cox regression analysis suggested that XCR1 is an independent risk factor for ccRCC. GSEA analysis suggested that XCR1 is associated with the JAK/STAT signaling pathway. XCR1 knockdown by small interfering RNA (siRNA) significantly increased ccRCC cell proliferation and migration, and decreased cell apoptosis.\nCONCLUSION: We found higher XCR1 expression in ccRCC compared with that in normal tissues is related to longer overall survival in patients with ccRCC. XCR1 knockdown significantly increased RCC cells proliferation and migration, and decreased apoptosis. XCR1 might be used as a prognostic biomarker in ccRCC in the future.", "claims": [{"id": "claim-method", "statement": "For association analysis between IHC samples and clinical‐pathological parameters analysis, the Pearson χ2 test was used.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:33377624", "locator": "sections[12] \"Statistical analysis\" paragraph 2", "quote": "For association analysis between IHC samples and clinical‐pathological parameters analysis, the Pearson χ2 test was used."}], "state": "complete"}, {"id": "claim-data-access", "statement": "The data of this study are available from the corresponding author upon reasonable request.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:33377624", "locator": "sections[24] \"DATA AVAILABILITY STATEMENT\" paragraph 2", "quote": "The data of this study are available from the corresponding author upon reasonable request."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "partial", "objective": null, "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:33377624"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "blocked", "blocked_on": "data:accession_absent", "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": ["step:obtain_source_data blocked on data:accession_absent"]}, "data": {"state": "partial", "assets": [{"id": "source:pmid:33377624", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1002/mgg3.1551", "sha256": "sha256:83314057bc52dff9b921e4474f1f1a12a70f87bcfce09158716a3995230b4369", "bytes": 27594, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1002/mgg3.1551", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC7963425", "source": "europe_pmc_fulltext", "coverage": "whole_body_without_references", "text_hash_scope": "rendered_section_body"}}, {"id": "asset:table:pmid:33377624:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:ee82daf49171e43162a2ffb549ed06807aa557a9194c79b674f472b5fba1d5be", "bytes": 406, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[7]/table-wrap[1]#mgg31551-tbl-0001", "version": null, "note": "Primer pairs used for real‐time PCR.", "structure": {"pmcid": "PMC7963425", "section_index": 7, "section_title": "RNA extraction, reverse transcription, and quantitative real‐time PCR", "row_count": 3, "column_count": 3}, "table": {"label": "Table 1", "caption": "Primer pairs used for real‐time PCR.", "rows": [["Gene", "Forward primer sequence (5′ to 3′)", "Reverse primer sequence (5′ to 3′)"], ["GAPDH", "CGCTGAGTACGTCGTGGAGTC", "GCTGATGATCTTGAGGCTGTTGTC"], ["XCR1", "TACCTCACCTCCGTCTACCA", "GATGAGCAGGGCGTATTCTA"]], "row_count": 3, "column_count": 3, "numeric_cells": 2, "header_rows": 1, "locator": "section[7]/table-wrap[1]#mgg31551-tbl-0001"}}, {"id": "asset:table:pmid:33377624:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:0f75e6632bfc58dc5d8b633589bf3e44d4abfc376896e129522df3993fe64080", "bytes": 684, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[14]/table-wrap[1]#mgg31551-tbl-0002", "version": null, "note": "Clinicopathological features of patients included in this study.", "structure": {"pmcid": "PMC7963425", "section_index": 14, "section_title": "Patient characteristics", "row_count": 22, "column_count": 3}, "table": {"label": "Table 2", "caption": "Clinicopathological features of patients included in this study.", "rows": [["", "TCGA database", "Clinical Samples"], ["Total", "539", "36"], ["Age", "26–90 (61)", "24–78 (56)"], ["Gender"], ["Male", "348", "23"], ["Female", "191", "13"], ["Grade"], ["G1", "14", "3"], ["G2", "230", "13"], ["G3", "207", "15"], ["G4", "78", "5"], ["NA", "10", "0"], ["TNM staging"], ["Ⅰ", "269", "11"], ["Ⅱ", "57", "15"], ["Ⅲ", "125", "8"], ["Ⅳ", "83", "2"], ["NA", "5", "0"], ["Follow‐up, months", "0–121", "20–83"], ["Survival condition"], ["Dead", "172", "8"], ["Alive", "367", "28"]], "row_count": 22, "column_count": 3, "numeric_cells": 34, "header_rows": 1, "locator": "section[14]/table-wrap[1]#mgg31551-tbl-0002"}}, {"id": "asset:table:pmid:33377624:3", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:56dca27834fc6e06d8a86501ce576dae25a22aaa79b849ef7d1b22d994d20394", "bytes": 690, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[16]/table-wrap[1]#mgg31551-tbl-0003", "version": null, "note": "Association between XCR1 expression and the clinic‐pathological characteristics of clinical samples from ccRCC patients.", "structure": {"pmcid": "PMC7963425", "section_index": 16, "section_title": "Correlation between XCR1 expression and ccRCC malignancy", "row_count": 18, "column_count": 4}, "table": {"label": "Table 3", "caption": "Association between XCR1 expression and the clinic‐pathological characteristics of clinical samples from ccRCC patients.", "rows": [["Characteristics", "Positive", "Negative", "P‐value"], ["Age", "", "", ""], ["<45", "7", "4", "0.984"], ["≥45", "16", "9", ""], ["", "", "", ""], ["Gender", "14", "9", ""], ["Male", "9", "4", "0.621"], ["female", "", ""], ["Grade", "2", "1", ""], ["Ⅰ", "5", "8", "0.125"], ["Ⅱ", "12", "3", ""], ["Ⅲ", "4", "1", ""], ["Ⅳ", "", "", ""], ["TNM staging", "8", "3", ""], ["Ⅰ", "3", "12", "0.019"], ["Ⅱ", "1", "7", ""], ["Ⅲ", "1", "1", ""], ["Ⅳ", "", "", ""]], "row_count": 18, "column_count": 4, "numeric_cells": 30, "header_rows": 1, "locator": "section[16]/table-wrap[1]#mgg31551-tbl-0003"}}, {"id": "asset:table:pmid:33377624:4", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:a69b139059ae2ea2876df46d01d56c219858b7b11576cdc4cde3a017edc05ec9", "bytes": 1055, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[16]/table-wrap[2]#mgg31551-tbl-0004", "version": null, "note": "Cox regression analysis of XCR1 mRNA levels and patient overall survival with ccRCC.", "structure": {"pmcid": "PMC7963425", "section_index": 16, "section_title": "Correlation between XCR1 expression and ccRCC malignancy", "row_count": 9, "column_count": 9}, "table": {"label": "Table 4", "caption": "Cox regression analysis of XCR1 mRNA levels and patient overall survival with ccRCC.", "rows": [["Variable", "Univariate analysis", "Multivariate analysis"], ["HR", "HR.95L", "HR.95H", "P value", "HR", "HR.95L", "HR.95H", "P value"], ["age", "1.032826", "1.019083", "1.046754", "2.29E−06", "1.034216", "1.018615", "1.050057", "1.44E−05"], ["Sex", "0.931081", "0.675354", "1.283641", "0.662937", "0.962538", "0.692753", "1.337389", "0.820013"], ["Grade", "2.293061", "1.854092", "2.835959", "1.94E−14", "1.652044", "1.294088", "2.109014", "5.60E−05"], ["Stage", "1.888786", "1.648774", "2.163737", "4.67E−20", "1.707664", "1.076801", "2.708128", "0.022938"], ["T", "1.94139", "1.639292", "2.29916", "1.50E−14", "0.86604", "0.566668", "1.32357", "0.506312"], ["M", "4.283544", "3.105734", "5.908024", "7.45E−19", "1.242764", "0.625942", "2.467424", "0.534532"], ["XCR1", "0.815312", "0.638049", "1.041823", "0.102594", "0.720596", "0.56334", "0.921749", "0.00909"]], "row_count": 9, "column_count": 9, "numeric_cells": 60, "header_rows": 2, "locator": "section[16]/table-wrap[2]#mgg31551-tbl-0004"}}, {"id": "asset:table:pmid:33377624:5", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:8e55112a74393e925d0e2de7dbf6e495835853d3f8e3f7f446cff14800131f43", "bytes": 648, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[17]/table-wrap[1]#mgg31551-tbl-0005", "version": null, "note": "Top five signaling pathways enriched in the XCR1 upregulation group.", "structure": {"pmcid": "PMC7963425", "section_index": 17, "section_title": "GSEA identified XCR1‐related signaling pathways", "row_count": 6, "column_count": 6}, "table": {"label": "Table 5", "caption": "Top five signaling pathways enriched in the XCR1 upregulation group.", "rows": [["Rank", "Name of pathway", "ES", "NES", "NOM p‐val", "FDR q‐val"], ["1", "HUNTINGTONS_DISEASE", "0.616067", "2.251294", "0", "0.01076"], ["2", "CARDIAC_MUSCLE_CONTRACTION", "0.614087", "2.145381", "0", "0.022747"], ["3", "OXIDATIVE_PHOSPHORYLATION", "0.806736", "2.122762", "0", "0.020029"], ["4", "BUTANOATE_METABOLISM", "0.714311", "2.092098", "0.004141", "0.019135"], ["5", "PARKINSONS_DISEASE", "0.716557", "2.081168", "0.001957", "0.017659"]], "row_count": 6, "column_count": 6, "numeric_cells": 25, "header_rows": 1, "locator": "section[17]/table-wrap[1]#mgg31551-tbl-0005"}}, {"id": "asset:table:pmid:33377624:6", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:23f65f535d45b04dd223a4a3005e3de7c0bfd1cf4a5cd453684203cca532eacf", "bytes": 1083, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[17]/table-wrap[2]#mgg31551-tbl-0006", "version": null, "note": "Top 10 signaling pathways enriched in the XCR1 downregulation group.", "structure": {"pmcid": "PMC7963425", "section_index": 17, "section_title": "GSEA identified XCR1‐related signaling pathways", "row_count": 11, "column_count": 6}, "table": {"label": "Table 6", "caption": "Top 10 signaling pathways enriched in the XCR1 downregulation group.", "rows": [["Rank", "Name of pathway", "Es", "NES", "NOM p‐val", "FDR q‐val"], ["1", "JAK STAT SIGNALING PATHWAY", "−0.6941993", "−2.92982", "0", "0"], ["2", "NON SMALL CELL LUNG CANCER", "−0.55117565", "−1.92028", "0.010204", "0.022405"], ["3", "ACUTE MYELOID LEUKEMIA", "−0.5652863", "−1.91111", "0.013834", "0.023524"], ["4", "VEGF SIGNALING PATHWAY", "−0.45163378", "−1.90325", "0", "0.02442"], ["5", "CHRONIC MYELOID LEUKEMIA", "−0.5741395", "−1.9007", "0.014553", "0.024273"], ["6", "PANCREATIC CANCER", "−0.56183416", "−1.88966", "0.02439", "0.025081"], ["7", "PATHWAYS IN CANCER", "−0.4609015", "−1.88757", "0.014315", "0.024817"], ["8", "SMALL CELL LUNG CANCER", "−0.5270194", "−1.83966", "0.022222", "0.030835"], ["9", "COLORECTAL CANCER", "−0.5336979", "−1.78094", "0.027083", "0.043837"], ["10", "RENAL CELL CARCINOMA", "−0.53083134", "−1.76747", "0.034836", "0.045633"]], "row_count": 11, "column_count": 6, "numeric_cells": 50, "header_rows": 1, "locator": "section[17]/table-wrap[2]#mgg31551-tbl-0006"}}], "gaps": []}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": "survival_analysis", "specific": "kaplan_meier", "label": "Survival analysis", "dsl_operations": ["survival_km"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.7, "band": "medium", "quote": "Kaplan-Meier"}}, {"id": "method-2", "family": "survival_analysis", "specific": "cox_proportional_hazards", "label": "Survival analysis", "dsl_operations": ["cox_ph"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.7, "band": "medium", "quote": "Cox regression"}}, {"id": "method-3", "family": "contingency_analysis", "specific": "chi_square", "label": "Categorical (contingency table) analysis", "dsl_operations": ["chi_square_test"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["categorical_cross_tabulation"], "evidence": {"score": 0.8, "band": "high", "quote": "χ2"}}, {"id": "method-4", "family": null, "specific": null, "label": "Pearson χ² test", "dsl_operations": [], "missing_operations": [], "expressible": null, "parameters": {}, "data_shapes": [], "evidence": {"score": 1.0, "band": "verbatim", "quote": "For association analysis between IHC samples and clinical‐pathological parameters analysis, the Pearson χ2 test was used."}}], "targets": [], "gaps": ["method.reader_named_unmapped"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "blocked", "tier": "R4", "blocking_axis": "data", "blocked_on": "data:accession_absent", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["survival_km"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: kaplan_meier."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R4", "reachable": false, "accessions": [], "resolved_accessions": [], "statements": ["The data of this study are available from the corresponding author upon reasonable request."], "basis": "The paper names no accession to its source data, so the data has to come from the authors."}}, "can_run": {"dsl_operations": ["survival_km"], "assets": ["source:pmid:33377624", "asset:table:pmid:33377624:1", "asset:table:pmid:33377624:2", "asset:table:pmid:33377624:3", "asset:table:pmid:33377624:4", "asset:table:pmid:33377624:5", "asset:table:pmid:33377624:6"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:None"]}, "gaps": ["data:accession_absent"]}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T18:25:34Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 3, "usage": {"prompt_tokens": 22004, "completion_tokens": 1258, "cached_tokens": 7432}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:33377624", "type": "paper", "label": "pmid:33377624"}, {"id": "source:pmid:33377624", "type": "manuscript", "label": "PMID 33377624 full text"}, {"id": "data:geo:None", "type": "dataset", "label": "GEO None"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:33377624", "type": "paper", "label": "pmid:33377624"}, {"id": "source:pmid:33377624", "type": "manuscript", "label": "PMID 33377624 full text"}, {"id": "data:geo:None", "type": "dataset", "label": "GEO None"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-33377624", "type": "extraction", "used": ["source:pmid:33377624"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-None", "type": "accession_resolution", "used": ["data:geo:None"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:33377624", "parent_hash": "sha256:018573f89779b532508840d668c4713df5bb02d7abc42f2d92574dbb942f9c87", "fork_of": null, "generation": 5}, "gaps": ["execution.not_run", "method.reader_named_unmapped", "review.human_critique", "review.independent_reader", "review.machine_critique", "step:obtain_source_data blocked on data:accession_absent"], "assays": [{"role": "data_generation", "definition_id": "ihc", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["CC, which was confirmed by qRT-PCR assay and immunohistochemical staining of ccRCC samples. RESULTS: For the", "ignificant. For association analysis between IHC samples and clinical‐pathological parameters"], "order_basis": "paper_text_order:629", "id": "assay:1"}, {"role": "data_generation", "definition_id": "transfection", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["ed with the JAK/STAT signaling pathway. XCR1 knockdown by small interfering RNA (siRNA) significant", "verall survival in patients with ccRCC. XCR1 knockdown significantly increased RCC cells proliferat", "ay. XCR1 knockdown by small interfering RNA (siRNA) significantly increased ccRCC cell prolifer"], "order_basis": "paper_text_order:1009", "id": "assay:2"}, {"role": "data_generation", "definition_id": "apoptosis_assay", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.93, "evidence": ["liferation and migration, and decreased cell apoptosis. CONCLUSION: We found higher XCR1 expression", "s proliferation and migration, and decreased apoptosis. XCR1 might be used as a prognostic biomarke"], "order_basis": "paper_text_order:1135", "id": "assay:3"}, {"role": "data_generation", "definition_id": "rna_seq", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.93, "evidence": ["ferential mRNA expression. Subsequently, the RNA sequencing (RNA‐Seq) gene expression level 3 HTSeq‐Coun"], "order_basis": "paper_text_order:1966", "id": "assay:4"}, {"role": "data_generation", "definition_id": "cell_culture", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.77, "evidence": ["ed from the ATCC (Manassas, VA, USA) and was cultured in Roswell Park Memorial Institute (RPMI)‐1640"], "order_basis": "paper_text_order:2524", "id": "assay:5"}, {"role": "analysis", "definition_id": "survival_analysis", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["survival_km"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 0.7, "evidence": ["Kaplan-Meier"], "order_basis": "consumes_earlier_output", "id": "assay:6"}]}